First Page | Document Content | |
---|---|---|
Date: 2010-08-10 22:47:20Glycogen storage disease type II Hepatology Alglucosidase alfa Medical genetics Desensitization Molecular genetics Enzyme replacement therapy Medicine Health Lysosomal storage diseases | Login: Register Home BrowseAdd to Reading ListSource URL: amdapompe.ehclients.comDownload Document from Source WebsiteFile Size: 169,43 KBShare Document on Facebook |
How one patient with a rare disease coped with his genetic disorderDocID: 1r9mW - View Document | |
MUCOPOLYSACCHARIDOSES Rare Diseases Unit of the Finnish Association of People with Physical Disabilities Support for this guide was provided by Genzyme.DocID: 1fJSQ - View Document | |
May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to ImDocID: 1aiEg - View Document | |
先進国における希少疾患対策の分析 -国際連携体制-DocID: 1aeuT - View Document | |
Microsoft Word - Apjohn Ventures Fund 2Q10 Letter FinalDocID: 19Qom - View Document |